John J. Abel Junior Independent Investigator Award
Forecasted
John J. Abel Junior Independent Investigator Award recognizes junior investigators’ achievements in general pharmacology to encourage fundamental research in pharmacology and experimental therapeutics.
Funder: American Society for Pharmacology and Experimental Therapeutics
Due Dates (Anticipated): September 2027 (Nomination deadline)
Funding Amounts: Scientific achievement recognition
Summary: Recognizes junior independent investigators for achievements in general pharmacology and encourages fundamental research in pharmacology and experimental therapeutics.
Key Information: Nominees must be junior independent investigators younger than 45.
Description
The John J. Abel Junior Independent Investigator Award is part of the American Society for Pharmacology and Experimental Therapeutics (ASPET) Scientific Achievement Awards program. Its area of specialty is general pharmacology, within a broader program recognizing accomplishments in particular fields and contributions to pharmacology as a whole. This is an achievement award rather than a project funding program.
Established in 1946 and named after ASPET’s founder, John Jacob Abel, the award aims to stimulate fundamental research in pharmacology and experimental therapeutics by young investigators. It recognizes researchers at the junior independent investigator stage, with an age limit of younger than 45.
